Ji T, Huang G, Cao Y, Gao Y, Gao X
J Inflamm Res. 2025; 18:3125-3141.
PMID: 40059944
PMC: 11889408.
DOI: 10.2147/JIR.S508031.
Zhang Z, Langenbach M, Sagar S, Fetsch V, Stritzker J, Severa E
Nat Immunol. 2024; 26(1):92-104.
PMID: 39702858
DOI: 10.1038/s41590-024-02027-0.
Sainatham C, Yadav D, Dilli Babu A, Tallapalli J, Kanagala S, Filippov E
Front Med (Lausanne). 2024; 11:1462307.
PMID: 39697210
PMC: 11652178.
DOI: 10.3389/fmed.2024.1462307.
Zu H, Chen X
Genes Immun. 2024; 25(6):525-540.
PMID: 39543311
DOI: 10.1038/s41435-024-00307-1.
Chen S, Zhu H, Jounaidi Y
Signal Transduct Target Ther. 2024; 9(1):302.
PMID: 39511139
PMC: 11544004.
DOI: 10.1038/s41392-024-02005-w.
A targetable type III immune response with increase of IL-17A expressing CD4 T cells is associated with immunotherapy-induced toxicity in melanoma.
Dimitriou F, Cheng P, Saltari A, Schaper-Gerhardt K, Staeger R, Haunerdinger V
Nat Cancer. 2024; 5(9):1390-1408.
PMID: 39210005
PMC: 11424476.
DOI: 10.1038/s43018-024-00810-4.
Identification of Gene Regulatory Networks in B-Cell Progenitor Differentiation and Leukemia.
Nagel S, Meyer C
Genes (Basel). 2024; 15(8).
PMID: 39202339
PMC: 11353346.
DOI: 10.3390/genes15080978.
LIM-domain-only 4 (LMO4) enhances CD8 T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling.
Schelker R, Fioravanti J, Mastrogiovanni F, Baldwin J, Rana N, Li P
Signal Transduct Target Ther. 2024; 9(1):199.
PMID: 39117617
PMC: 11310520.
DOI: 10.1038/s41392-024-01915-z.
Key Functions of the Transcription Factor BCL6 During T-Cell Differentiation.
Konstantakopoulou C, Verykokakis M
Adv Exp Med Biol. 2024; 1459:79-94.
PMID: 39017840
DOI: 10.1007/978-3-031-62731-6_4.
Memory CD8 T cells are vulnerable to chronic IFN-γ signals but not to CD4 T cell deficiency in MHCII-deficient mice.
Setoguchi R, Sengiku T, Kono H, Kawakami E, Kubo M, Yamamoto T
Nat Commun. 2024; 15(1):4418.
PMID: 38806459
PMC: 11133459.
DOI: 10.1038/s41467-024-48704-4.
Tuberculosis Vaccines and T Cell Immune Memory.
Li F, Dang W, Du Y, Xu X, He P, Zhou Y
Vaccines (Basel). 2024; 12(5).
PMID: 38793734
PMC: 11125691.
DOI: 10.3390/vaccines12050483.
Promising Cytokine Adjuvants for Enhancing Tuberculosis Vaccine Immunity.
Cao X, Fu Y, Peng H
Vaccines (Basel). 2024; 12(5).
PMID: 38793728
PMC: 11126114.
DOI: 10.3390/vaccines12050477.
Immunometabolism of CD8 T cell differentiation in cancer.
Shi H, Chen S, Chi H
Trends Cancer. 2024; 10(7):610-626.
PMID: 38693002
PMC: 11342304.
DOI: 10.1016/j.trecan.2024.03.010.
Development of a chimeric cytokine receptor that captures IL-6 and enhances the antitumor response of CAR-T cells.
Yoshikawa T, Ito Y, Wu Z, Kasuya H, Nakashima T, Okamoto S
Cell Rep Med. 2024; 5(5):101526.
PMID: 38670095
PMC: 11148643.
DOI: 10.1016/j.xcrm.2024.101526.
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases.
Zhao Y, Chen J, Andreatta M, Feng B, Xie Y, Wenes M
Nat Biotechnol. 2024; 42(11):1693-1704.
PMID: 38168996
DOI: 10.1038/s41587-023-02060-8.
STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient.
Zhang S, Yan J, He L, Jiang Z, Jiang H
Cancer Gene Ther. 2023; 31(3):484-494.
PMID: 38135698
DOI: 10.1038/s41417-023-00719-7.
DIALing-up the preclinical characterization of gene-modified adoptive cellular immunotherapies.
Giardino Torchia M, Moody G
Front Immunol. 2023; 14:1264882.
PMID: 38090585
PMC: 10713823.
DOI: 10.3389/fimmu.2023.1264882.
IL-27 produced during acute malaria infection regulates Plasmodium-specific memory CD4 T cells.
Macalinao M, Inoue S, Tsogtsaikhan S, Matsumoto H, Bayarsaikhan G, Jian J
EMBO Mol Med. 2023; 15(12):e17713.
PMID: 37855243
PMC: 10701605.
DOI: 10.15252/emmm.202317713.
Reshaping Our Knowledge: Advancements in Understanding the Immune Response to Human Respiratory Syncytial Virus.
Attaianese F, Guiducci S, Trapani S, Barbati F, Lodi L, Indolfi G
Pathogens. 2023; 12(9).
PMID: 37764926
PMC: 10536346.
DOI: 10.3390/pathogens12091118.
Reduces Tumor Burden and Metastasis and Regulates the Peripheral Immune Response in a Murine Myeloid Leukemia Model.
Murillo N, Lasso P, Uruena C, Pardo-Rodriguez D, Ballesteros-Ramirez R, Betancourt G
Int J Mol Sci. 2023; 24(16).
PMID: 37629156
PMC: 10454792.
DOI: 10.3390/ijms241612972.